Company Overview and News

4
3 Fast Growing, High-Yield Dividend Stocks To Own For The Next 50 Years

2018-09-18 seekingalpha
History has shown that buying and holding high-yield dividend growth stocks for decades is a great way to compound both your income and wealth.
BAMGF ENBBF NEP ENB ENB DM EBBNF BIP BAMKF BAM NEE

1
Brookfield Global Infrastructure Securities Income Fund Announces Quarterly Distribution

2018-09-18 globenewswire
TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Brookfield Global Infrastructure Securities Income Fund (the “Fund”) (TSX: BGI.UN) today announced a distribution of C$0.15 per unit for the quarter ending September 30, 2018. The distribution will be paid on or before October 15, 2018 to holders of record on September 28, 2018.
BAMGF BAMKF BAM

1
Brookfield Select Opportunities Income Fund Announces Quarterly Distribution

2018-09-18 globenewswire
TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Brookfield Select Opportunities Income Fund (the “Fund”) (TSX: BSO.UN) announces a distribution of C$0.15 per unit for the quarter ending September 30, 2018. The distribution will be paid on or before October 15, 2018 to holders of record on September 28, 2018.
BAMGF BAMKF BAM

2
Brookfield Renewable to Issue CDN$300 Million Green Bond

2018-09-18 globenewswire
BROOKFIELD, NEWS, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Brookfield Renewable Partners L.P. (TSX: BEP.UN; NYSE: BEP) (“Brookfield Renewable”) today announced that it has agreed to issue CDN$300 million aggregate principal amount of medium-term notes, Series 11, due January 15, 2029, which will bear interest at a rate of 4.25% per annum, payable semi-annually (the “Notes”). The Notes will be fully and unconditionally guaranteed by Brookfield Renewable and certain of its key holding subsidiaries.
BAMGF BAMKF BAM BEP

1
Toshiba plays down Moorside nuclear sale as ‘speculation’

2018-09-18 telegraph.co.uk
The Japanese conglomerate behind plans for Europe’s largest nuclear reactor has rubbished claims that it is in talks with a major Canadian asset manager to sell the troubled project.
BAMGF BAMKF BAM

7
Johnson Controls to Finalize Bidders for Sale of Power Unit

2018-09-18 zacks
Per Reuters, Johnson Controls International plc’s (JCI - Free Report) power solutions business will soon have two shortlisted bidders, as informed by banking sources. In order to back the company’s unit sales, these banks are working on a jumbo debt financing of more than $10 billion. The buyout of Johnson Control’s power solutions unit, which manufactures advanced batteries for vehicles, is expected to generate approximately $12 billion.
BAMGF MTSI MDPEB PCAR ALSN MDP JCI BAMKF APO BAM

1
UPDATE 1-Toshiba in talks with Brookfield for UK nuke unit sale - source

2018-09-18 reuters
TOKYO, Sept 18 (Reuters) - Toshiba Corp is in talks with Canada’s Brookfield Asset Management Inc for the potential sale of its UK nuclear unit NuGen, a source familiar with the matter said on Tuesday.
BAMGF KEP BAMKF BAM

1
Toshiba in talks with Brookfield for sale of UK nuclear unit - FT

2018-09-18 reuters
Sept 18 (Reuters) - Toshiba Corp is in talks with Canada’s Brookfield Asset Management Inc for the potential sale of its UK nuclear unit NuGen, the Financial Times reported on Tuesday, citing two people familiar with the matter.
BAMGF BAMKF BAM

4
Simon Property Group: The Top SWAN In Retail Real Estate

2018-09-17 seekingalpha
I initially favored SKT over SPG, but have since learned that - especially in retail - quality matters.
VTR BAMGF BPY TCO SPG GGP KIM BAMKF BAM BPR

11
Deals Buzz: Brookfield to acquire Ambani gas pipeline

2018-09-17 livemint
Canadian asset manager Brookfield Asset Management is set to buy the loss-making East West Pipeline Ltd (EWPL), earlier known as Reliance Gas Transportation Infrastructure Ltd, for an enterprise valuation of ₹ 14,000 crore ($2 billion), The Economic Times reported. The Competition Commission of India (CCI) approved the transaction last week. Mint had in June that Brookfield is looking to focus on the renewable energy space in India.
BAMGF 500325 RELIANCE GMQRY GMRINFRA SFTBF 532754 BABA RIGD 9984 BAMKF BAM SFTBY RLNIY

2
Real Estate Sector Awaits Impact From Hurricane Florence

2018-09-15 seekingalpha
On a busy week of economic data and hurricane-related disruptions, US equities advanced 1% while real estate equities finished roughly flat. Housing-related categories await the impact of Hurricane Florence.
HD BAMGF DRE EQIX LEN CG CLGX MDC BAMKF BAM

1
Dream Global REIT Appoints New CFO

2018-09-14 globenewswire
TORONTO, Sept. 14, 2018 (GLOBE NEWSWIRE) -- DREAM GLOBAL REIT (TSX: DRG.UN, FRA: DRG) is pleased to announce the appointment of Mr. Rajeev Viswanathan as the Trust’s Chief Financial Officer effective September 14, 2018.
DRG.UN BAMGF BAMKF BAM D.UN

9
Redmond Overlake Plaza: One Reason Why Valuing Seritage Growth Is Difficult

2018-09-13 seekingalpha
The balance sheet numbers based on how the property sits now don’t help us understand the future economics.
SHLD BAMGF GGP BAMKF BAM

1
iCapital(R) Network Hires Robert Worthington as Managing Director, Client Solutions

2018-09-12 accesswire
Strengthens Education and Distribution Efforts to Support Growing Demand for Alternative Investments from the Independent Advisory Space
BAMGF BAMKF BAM

1
Pipeline Infrastructure-India Infrastructure Trust deal gets CCI nod

2018-09-11 moneycontrol
The Competition Commission of India has approved the acquisition of Reliance Industries Holding's subsidiary Pipeline Infrastructure by India Infrastructure Trust, according to a communication. The Trust is proposed to be registered as an infrastructure investment trust (InvIT).
BAMGF BAMKF BAM

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to BAM / Brookfield Asset Management, Inc. on message board site Silicon Investor.

President Barack Obama President Barack Obama President Barack Obama The Obama - Clinton Disaster The Obama - Clinton Disaster The Obama - Clinton Disaster
Obama Joke Thread Obama Joke Thread Obama Joke Thread Fast and Furious-----Obama/Holder Gun Running Scandal Fast and Furious-----Obama/Holder Gun Running Scandal Fast and Furious-----Obama/Holder Gun Running Scandal
Obama and Michelleu0027s Shocking Spending Sprees Obama and Michelleu0027s Shocking Spending Sprees Obama and Michelleu0027s Shocking Spending Sprees Alabama Graphite Company, Inc. Alabama Graphite Company, Inc. Alabama Graphite Company, Inc.
Brookfield Asset Management Brookfield Asset Management Brookfield Asset Management President Barack Obamau0027s Complete List of Historic Firsts President Barack Obamau0027s Complete List of Historic Firsts President Barack Obamau0027s Complete List of Historic Firsts
How Quickly Can Obama Totally Destroy the US? How Quickly Can Obama Totally Destroy the US? How Quickly Can Obama Totally Destroy the US? ILLEGAL ALIEN NATION---THE SOROS/OBAMA USA ILLEGAL ALIEN NATION---THE SOROS/OBAMA USA ILLEGAL ALIEN NATION---THE SOROS/OBAMA USA
CUSIP: 112585104